Yi Zhang

Yi Zhang currently serves as Senior Director of Clinical Science at Schrödinger since January 2023. Prior experience includes key roles at Regeneron Pharmaceuticals, where responsibilities spanned from Health Economics and Outcomes Research to Director of Clinical Pharmacology, and at Novartis Oncology as a Clinical Pharmacology Manager. Earlier career highlights feature positions at Genentech as an Associate Scientist, at Centocor as a Postdoc fellow in Pharmacometrics, and academic training as a Graduate Student at the University of Washington. Yi Zhang holds a Master of Public Health from Columbia University, a Ph.D. in Pharmaceutics from the University of Washington, an M.S. in Chemistry from Texas State University, and undergraduate education at China Pharmaceutical University.